Cabaletta Bio (CABA) Change in Acquisitions & Divestments (2020 - 2025)
Cabaletta Bio (CABA) recorded quarterly Change in Acquisitions & Divestments of $50.0 million in Q4 2025, up 300.0% quarter-over-quarter from $12.5 million in Q4 2024, and up 300.0% on a YoY basis from $12.5 million in Q4 2024.
Cabaletta Bio (CABA) Change in Acquisitions & Divestments (2020 - 2025) Analysis & Trends
Cabaletta Bio's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $50.0 million for Q4 2025.
- In Q4 2025, Change in Acquisitions & Divestments rose 300.0% year-over-year to $50.0 million; the TTM figure through Dec 2025 stood at $75.0 million (up 51.52% YoY), while the FY2025 annual figure was $50.0 million, up 1.01% from the prior year.
- Change in Acquisitions & Divestments was $50.0 million for Q4 2025 at Cabaletta Bio, up from $12.5 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $50.0 million in Q4 2025 to a low of $1.0 million in Q4 2021.
- Historically, Change in Acquisitions & Divestments has averaged $17.7 million across 5 years, with a median of $12.5 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments jumped 986.96% in 2022, then slumped 66.67% in 2024.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $1.0 million in 2021, then surged by 2400.0% to $25.0 million in 2022, then surged by 50.0% to $37.5 million in 2023, then tumbled by 66.67% to $12.5 million in 2024, then surged by 300.0% to $50.0 million in 2025.
- The last three Change in Acquisitions & Divestments figures came in at $50.0 million (Q4 2025), $12.5 million (Q4 2024), and $12.5 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.00 Mn |
| Dec 31, 2025 | 50.00 Mn |
| Dec 31, 2024 | 12.50 Mn |
| Dec 31, 2024 | 12.50 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 24.50 Mn |
| Jun 30, 2024 | 24.50 Mn |
| Dec 31, 2023 | 37.50 Mn |
| Dec 31, 2023 | 37.50 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.42 Mn |